Sunsho Pharmaceutical Develops New Tablet Production Method
This article was originally published in PharmAsia News
Executive SummaryShizuoka-based Sunsho Pharmaceutical developed Tablart, a new method of using collagen membranes to coat tablets. Compared to current sugar coating method, the production cost stays the same; however, the new method reduces diluent usage. By reducing tablet diluent usage and making room for more active ingredients, the method also aims to reduce size of tablets. The company has planned to sign original equipment manufacturing contacts with health products makers for mass production. (Click here for more - Japanese language
You may also be interested in...
ConMed’s ambitions in orthopedics are to be the clinician’s support, develop differentiated offerings and avoid “me too” activity, before all notions of leading the market rankings.
Executives On The Move: Tech And Science Announcements At Orexo And Agios, And Board Changes At Accorda And RhoVac
Swedish pharma Orexo welcomes EVP, digital health and anti-cancer therapeutics firm Agios Pharmaceuticals announces Bristol-Myers Squibb exec as its next CSO. And a chair takes a seat at Accorda Therapeutics and RhoVac.
In 2018, the top 100 publicly listed and reportable medical device technology companies had global sales spanning from over $30bn to some $100m in the lower reaches. As the latest In Vivo Medtech 100 ranking shows, many of the major changes in value sales were linked to company restructurings. But there were some impressive organic gains too.